Humankind Investments’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Sell |
10,617
-4,989
| -32% | -$138K | 0.07% | 110 |
|
|
2025
Q1 | $442K | Buy |
15,606
+1,179
| +8% | +$33.4K | 0.11% | 95 |
|
|
2024
Q4 | $600K | Buy |
14,427
+8,638
| +149% | +$359K | 0.15% | 74 |
|
|
2024
Q3 | $387K | Buy |
5,789
+2,206
| +62% | +$147K | 0.14% | 94 |
|
|
2024
Q2 | $425K | Sell |
3,583
-3,440
| -49% | -$409K | 0.11% | 93 |
|
|
2024
Q1 | $748K | Sell |
7,023
-613
| -8% | -$65.3K | 0.2% | 60 |
|
|
2023
Q4 | $759K | Buy |
7,636
+1,882
| +33% | +$187K | 0.23% | 55 |
|
|
2023
Q3 | $594K | Buy |
5,754
+1,055
| +22% | +$109K | 0.25% | 53 |
|
|
2023
Q2 | $571K | Buy |
4,699
+2,533
| +117% | +$308K | 0.22% | 58 |
|
|
2023
Q1 | $333K | Buy |
2,166
+215
| +11% | +$33K | 0.14% | 83 |
|
|
2022
Q4 | $350K | Sell |
1,951
-491
| -20% | -$88.2K | 0.15% | 84 |
|
|
2022
Q3 | $289K | Buy |
2,442
+216
| +10% | +$25.6K | 0.14% | 82 |
|
|
2022
Q2 | $318K | Sell |
2,226
-33
| -1% | -$4.71K | 0.15% | 78 |
|
|
2022
Q1 | $389K | Buy |
2,259
+1,081
| +92% | +$186K | 0.16% | 78 |
|
|
2021
Q4 | $299K | Buy |
1,178
+438
| +59% | +$111K | 0.38% | 78 |
|
|
2021
Q3 | $285K | Sell |
740
-336
| -31% | -$129K | 0.43% | 74 |
|
|
2021
Q2 | $253K | Buy |
+1,076
| New | +$253K | 0.45% | 70 |
|